HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

American Beauty: Wonderful fragrance for women is positioned to "encapsulate that feeling of casual elegance and the perfect moment of everyday life," Estee Lauder's BeautyBank division announces. Scent opens with notes of wild poppy, primrose, white gardenia and pink peony, blending to a heart of wild honeysuckle, bergamot, orange and magnolia accords. Drydown comprises notes of California redwood and jasmine, and also features Mackayi orchid to add "depth and femininity," BeautyBank says. Wonderful is bowing in Kohl's department stores, retailing in a 1.7 oz. edp for $37.50 and 5 oz. body lotion for $22.50...

You may also be interested in...



BeautyBank Targets Women In Their 30s With Fuentes Fragrances

BeautyBank will back the launch of Daisy Fuentes' Dianoche fragrance for women with 1 mil. scented impressions, including vial-on-cards and dual-scented blow-ins, according to the Estee Lauder division

BeautyBank Targets Women In Their 30s With Fuentes Fragrances

BeautyBank will back the launch of Daisy Fuentes' Dianoche fragrance for women with 1 mil. scented impressions, including vial-on-cards and dual-scented blow-ins, according to the Estee Lauder division

Nivea Launch Targets 45% Of Men Who Claim To Have Oily Skin

Nivea For Men Oil Control addresses an untapped niche in men's skin care in the mass market, according to the Beiersdorf division

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel